Photocatalytic Degradation of Cell Membrane Coatings for Controlled Drug Release

    loading  Checking for direct PDF access through Ovid


Biomimetic cell-membrane–camouflaged particles with desirable features have been widely used for various biomedical applications. However, there are few reports on employing these particles for cancer drug delivery due to the failure of the membrane coatings to be efficiently degraded in the tumor microenvironment which hampers the drug release. In this work, core–shell SiO2@TiO2 nanoparticles with enhanced photocatalytic activity are used for controlled degradation of surface erythrocyte membrane coatings. The antitumor drug docetaxel is encapsulated into nanocarriers to demonstrate the controlled drug release under ultraviolet irradiation, and the drug-loaded nanoparticles are further used for enhanced cancer cell therapy. Here, a simple but practical method for degradation of cell membrane coatings is presented, and a good feasibility of using cell membrane–coated nanocarriers for controlled drug delivery is demonstrated.

Related Topics

    loading  Loading Related Articles